EQ ▼ -8.9% - Equillium, Inc.
$EQ - Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
26-OCT-2026 08:30 AM ET
Share this post
More filings for $EQ
EQ ▼ -5.6% - Equillium, Inc.Nov 12, 2026EQ - Equillium, Inc. - SEC Filing Update (12-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 12, 2026EQ ▼ -5.0% - Equillium, Inc.Nov 5, 2026EQ - Equillium, Inc. - SEC Filing Update (04-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 4, 2026EQ ▼ -1.4% - Equillium, Inc.Oct 6, 2026EQ ▲ +7.1% - Equillium, Inc.Oct 5, 2026
View full $EQ filing history →💬 Comments
Loading comments…
Leave a comment